Award
National Cancer Institute 1R01CA291848-01A1
Targeting EZH2 in advanced prostate cancer
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$497,972.00
Ceiling
$497,972.00
Awarded
March 30, 2026
Identifier
1R01CA291848-01A1
Award for research to develop and evaluate EZH2-targeting therapies for advanced prostate cancer using PROTAC technology.
Description
This NIH grant aims to develop and evaluate EZH2-targeting therapies for advanced prostate cancer, including CRPC, using PROTAC technology and preclinical models.